Loading...
Efinaconazole in the treatment of onychomycosis
Efinaconazole 10% topical solution is a new triazole recently approved for the treatment of onychomycosis. It inhibits fungal lanosterol 14α-demethylase in the ergosterol biosynthesis pathway, has potent antifungal activity against dermatophytes, as well as activity against Candida spp. and non-derm...
Saved in:
| Published in: | Infect Drug Resist |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4459619/ https://ncbi.nlm.nih.gov/pubmed/26082652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S69596 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|